Avandia Lawsuit in North Carolina
Avandia (Rosiglitazone) is prescribed to people with type 2 (non-insulin dependent) diabetes. taken by mouth, it helps to control blood sugar levels by making the body more sensitive to the action of insulin.
It has been sold in the United States since 1999, when it was approved by the Food and Drug Administration. Avandia was heavily marketed and quickly became one of the biggest selling products manufactured by GlaxoSmithKline, a major pharmaceutical company based in London. The total sales of Avandia were $3.4 billion in 2006.
“Despite existing warnings, these drugs were being prescribed to patients with significant heart failure.” – written statement accompanying the F.D.A. decision to issue the safety warning on Avandia in 2007.
The November 24, 2008 issue of Archives of Internal Medicine published a paper that studied almost 30,000 diabetic patients over the age of 65. 49.7% of these patients had been prescribed Avandia; 50.3%, another popular drug used for treatment of type 2 diabetes, Actos. 1,869 of the patients were dead a year later. The study showed that in patients who had been prescribed Avandia, the rate of death was 15% higher than in those prescribed Actos.
Severe and even fatal responses to Avandia have been reported, such as:
- Heart attack
- Congestive heart failure
- Heart valve disease
If you or a loved one have been prescribed Avandia and have experienced any of these symptoms, please contact a Raleigh pharmaceutical litigation attorney immediately for a free consultation at 919-351-8827. Consult with your physician before you stop taking any medications, including Avandia.
If we can be of service to you, your family or friends, please do not hesitate to call or contact us online.